COMPANY PROFILE
| Price and Volume | |
|---|---|
| Recent Price | 3.99 |
| 52 Week High | 5.70 |
| 52 Week Low | 1.05 |
| Avg. Daily Vol. (Mil) | 0.06 |
| Beta (3 year) | 1.82 |
| Share Related Items | |
| Mkt Cap (Mil) | 82.51 |
| Shares Out (Mil) | 20.68 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.00 |
| Current Ratio | 2.30 |
| LT Debt/ Equity | 0.23 |
| Total Debt / Equity | 0.42 |
| Valuation Ratios | |
| Price Earnings | N.A. |
| Price/Sales | 0.64 |
| Price/Book | 1.08 |
| Price/Cash Flow | -1.30 |
| Per Share Data | |
| Earnings | -2.40 |
| Sales | 6.24 |
| Book Value | 3.68 |
| Cash Flow | -3.15 |
| Business Summary | |
|---|---|
| The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. | |
| General Information | |
| One Southern Cross
Ida Business Park, Bray Wicklow, 18 |
|
| www.trinitybiotech.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 711 | |
| CEO: Ronan O'Caoimh | |
| Short Interest | |
| Current Month (Mil) | 0.02 |
| Previous Month (Mil) | 0.03 |
| Short Interest Ratio (Days) | 0.40 |
| Management Effectiveness | |
| Return on Equity | N.A. |
| Return on Assets | -56.10 |
| Return on Investments | -77.00 |
| Profitability | |
| Gross Margin | 52.20 |
| EBIT Margin | -58.10 |
| Profit Margin | -56.60 |